Suggestions
Rod O'Reilly
Strategic Advisor/Board Member
Rod O'Reilly is an experienced healthcare technology executive who was recently appointed as Chairman of the Board at Edifecs, a global health information technology solutions company, effective September 6, 2023.12
Professional Background
O'Reilly brings extensive experience in healthcare technology leadership:
- He has spent over 25 years in executive leadership roles.3
- Previously served as EVP and President of Software and Analytics at Change Healthcare (now Optum Insight).1
- Held multiple senior executive positions at McKesson Corporation, leading various healthcare solutions business units.1
Current Roles
In addition to his new position at Edifecs, O'Reilly holds several other leadership roles:
- Non-executive Chairman of the Board for Augmedix, a medical documentation and data solution company.13
- Board member for KLAS Research, a healthcare industry research firm.1
- Board member for Prescryptive Health, a healthcare consumer-focused mobile communication tool.1
- Board member for Rhapsody Health, a healthcare data interoperability company.1
Education
O'Reilly has a strong educational background in business and finance:
- Bachelor's Degree in Business Administration with a joint major in Economics and Finance from Simon Fraser University, Burnaby, British Columbia.13
- Master of Business Administration from the University of British Columbia, Vancouver.13
Expertise and Vision
O'Reilly is known for his:
- Passion for driving fundamental change in the healthcare system to make it more affordable, accessible, and effective.1
- Expertise in scaling organizations for long-term growth.2
- Deep knowledge of how the US healthcare system functions.1
His LinkedIn profile can be found under the username rod-o-reilly-057a9a86.4
Highlights
Sep 14 · healthcare-digital.com
Rod O'Reilly leading healthcare technology at Edifecs
Sep 6 · edifecs.com
Edifecs Names Rod O'Reilly Chairman of the Board
Sep 6 · finance.yahoo.com
Edifecs Names Rod O'Reilly Chairman of the Board - Yahoo Finance